metaraminol has been researched along with Coronary Occlusion in 1 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MUNE, O | 1 |
| NORREGAARD, S | 1 |
1 other study available for metaraminol and Coronary Occlusion
| Article | Year |
|---|---|
[Metaraminol (aramine) therapy of shock due to coronary occlusion].
Topics: Cardiotonic Agents; Convulsive Therapy; Coronary Disease; Coronary Occlusion; Metaraminol; Shock; Sy | 1959 |